Baker Brothers Advisors - XENON PHARMACEUTICALS INC ownership

XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 160 filers reported holding XENON PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.16 and the average weighting 0.5%.

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of XENON PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$25,675,988
-11.3%
751,6390.0%0.15%
-11.4%
Q2 2023$28,938,102
+7.6%
751,6390.0%0.17%
+14.4%
Q1 2023$26,901,160
-9.2%
751,6390.0%0.15%
-18.0%
Q4 2022$29,637,126
+9.2%
751,6390.0%0.18%0.0%
Q3 2022$27,134,000
+18.7%
751,6390.0%0.18%
+36.9%
Q2 2022$22,865,000
-0.5%
751,6390.0%0.13%
-1.5%
Q1 2022$22,978,000
-2.1%
751,6390.0%0.13%
+15.8%
Q4 2021$23,481,000
+104.4%
751,6390.0%0.11%
+128.0%
Q3 2021$11,485,000
-17.9%
751,6390.0%0.05%
-18.0%
Q2 2021$13,996,000
+4.0%
751,6390.0%0.06%
+5.2%
Q1 2021$13,454,000
+27.3%
751,639
+9.3%
0.06%
+45.0%
Q4 2020$10,572,000
+25.6%
687,386
-9.6%
0.04%
+17.6%
Q3 2020$8,417,000
-16.0%
760,308
-4.9%
0.03%
-22.7%
Q2 2020$10,021,000799,1020.04%
Other shareholders
XENON PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 266,961$9,119,38810.70%
COMMODORE CAPITAL LP 1,845,000$63,025,2007.37%
TLS Advisors LLC 32,956$1,1264.56%
Altium Capital Management LP 228,000$7,788,4804.06%
Paradigm Biocapital Advisors LP 1,491,835$50,961,0843.46%
GREAT POINT PARTNERS LLC 500,001$17,080,0343.11%
DAFNA Capital Management LLC 280,538$9,583,1782.98%
Nan Fung Group Holdings Ltd 106,680$3,644,1892.95%
Affinity Asset Advisors, LLC 300,438$10,262,9622.89%
Avoro Capital Advisors LLC 4,900,000$167,384,0002.61%
View complete list of XENON PHARMACEUTICALS INC shareholders